The Relevance of Kinin B1 Receptor Upregulation in a Mouse Model of Colitis

Overview

Journal Br J Pharmacol

Publisher Wiley

Specialty Pharmacology

Date 2008 Jun 10

PMID 18536758

Citations 11

Authors

D B Hara

D F P Leite

E S Fernandes

G F Passos

A O Guimaraes

J B Pesquero

M M Campos

J B Calixto

Affiliations

Soon will be listed here.

Abstract

Background And Purpose: Kinins are implicated in many pathophysiological conditions, and recent evidence has suggested their involvement in colitis. This study assessed the role of the kinin B1 receptors in a mouse model of colitis.

Experimental Approach: Colitis was induced in mice by 2,4,6-trinitrobenzene sulphonic acid (TNBS), and tissue damage and myeloperoxidase activity were assessed. B1 receptor induction was analysed by organ bath studies, binding assay and reverse transcription PCR.

Key Results: TNBS-induced colitis was associated with tissue damage, neutrophil infiltration and time-dependent increase of colon B1 receptor-mediated contraction, with the maximal response observed at 72 h. The upregulation of the B1 receptor at this time point was also confirmed by means of binding studies. B1 receptor mRNA levels were elevated as early as 6 h after colitis induction and remained high for up to 48 h. TNBS-evoked tissue damage and neutrophil influx were reduced by the selective B1 receptor antagonist SSR240612, and in B1 receptor knockout mice. In vivo treatment with inhibitors of protein synthesis, nuclear factor-kappaB activation, inducible nitric oxide synthase (iNOS) or tumour necrosis factor alpha (TNFalpha) significantly reduced B1 receptor agonist-induced contraction. Similar results were observed in iNOS and TNF receptor 1-knockout mice.

Conclusions And Implications: These results provide convincing evidence on the role of B1 receptors in the pathogenesis of colitis. Therefore, the blockade of kinin B1 receptors might represent a new therapeutic option for treating inflammatory bowel diseases.

Citing Articles

Dextran sodium sulfate-induced colitis in male BALB/c mice leads to albuminuria and increased markers of inflammation and tissue damage in the kidney.

Salmenkari H, Adeshara K, Pirttiniemi A, Linden J, Lehtonen S, Sandholm N Physiol Rep. 2025; 13(5):e70161.

PMID: 40018982 PMC: 11868992. DOI: 10.14814/phy2.70161.

Novel Insights into the Kallikrein-Kinin System in Fulminant Myocarditis: Physiological Basis and Potential Therapeutic Advances.

Ji M, Ran X, Zuo H, Zhang Q J Inflamm Res. 2024; 17:7347-7360.

PMID: 39429854 PMC: 11490248. DOI: 10.2147/JIR.S488237.

Renal and vascular effects of kallikrein inhibition in a model of Lonomia obliqua venom-induced acute kidney injury.

Berger M, de Moraes J, Beys-da-Silva W, Santi L, Terraciano P, Driemeier D PLoS Negl Trop Dis. 2019; 13(2):e0007197.

PMID: 30763408 PMC: 6392336. DOI: 10.1371/journal.pntd.0007197.

The Gut-Kidney Axis: Putative Interconnections Between Gastrointestinal and Renal Disorders.

Lehto M, Groop P Front Endocrinol (Lausanne). 2018; 9:553.

PMID: 30283404 PMC: 6157406. DOI: 10.3389/fendo.2018.00553.

Contact pathway of coagulation and inflammation.

Wu Y Thromb J. 2015; 13:17.

PMID: 25949215 PMC: 4421925. DOI: 10.1186/s12959-015-0048-y.

References

MacMicking J, Nathan C, Hom G, Chartrain N, Fletcher D, Trumbauer M . Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell. 1995; 81(4):641-50. DOI: 10.1016/0092-8674(95)90085-3. View

Cuthbert A, Margolius H . Kinins stimulate net chloride secretion by the rat colon. Br J Pharmacol. 1982; 75(4):587-98. PMC: 2071531. DOI: 10.1111/j.1476-5381.1982.tb09178.x. View

Stadnicki A . Tissue and plasma kallikrein in inflammatory bowel disease. Dig Liver Dis. 2005; 37(9):648-50. DOI: 10.1016/j.dld.2005.04.012. View

El Sayah M, Medeiros R, Fernandes E, Campos M, Calixto J . Mechanisms underlying lipopolysaccharide-induced kinin B1 receptor up-regulation in the pig iris sphincter in vitro. Mol Pharmacol. 2006; 69(5):1701-8. DOI: 10.1124/mol.105.021097. View

Moreau M, Garbacki N, Molinaro G, Brown N, Marceau F, Adam A . The kallikrein-kinin system: current and future pharmacological targets. J Pharmacol Sci. 2005; 99(1):6-38. DOI: 10.1254/jphs.srj05001x. View

Fries W, Muja C, Crisafulli C, Cuzzocrea S, Mazzon E . Dynamics of enterocyte tight junctions: effect of experimental colitis and two different anti-TNF strategies. Am J Physiol Gastrointest Liver Physiol. 2008; 294(4):G938-47. DOI: 10.1152/ajpgi.00469.2007. View

Wallace J, Macnaughton W, Morris G, Beck P . Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease. Gastroenterology. 1989; 96(1):29-36. DOI: 10.1016/0016-5085(89)90760-9. View

Hara D, Fernandes E, Campos M, Calixto J . Pharmacological and biochemical characterization of bradykinin B2 receptors in the mouse colon: influence of the TNBS-induced colitis. Regul Pept. 2007; 141(1-3):25-34. DOI: 10.1016/j.regpep.2006.12.013. View

Beck P, Xavier R, Wong J, Ezedi I, Mashimo H, Mizoguchi A . Paradoxical roles of different nitric oxide synthase isoforms in colonic injury. Am J Physiol Gastrointest Liver Physiol. 2003; 286(1):G137-47. DOI: 10.1152/ajpgi.00309.2003. View

10.

Campos M, Leal P, Yunes R, Calixto J . Non-peptide antagonists for kinin B1 receptors: new insights into their therapeutic potential for the management of inflammation and pain. Trends Pharmacol Sci. 2006; 27(12):646-51. DOI: 10.1016/j.tips.2006.10.007. View

11.

Ni A, Chao L, Chao J . Transcription factor nuclear factor kappaB regulates the inducible expression of the human B1 receptor gene in inflammation. J Biol Chem. 1998; 273(5):2784-91. DOI: 10.1074/jbc.273.5.2784. View

12.

Scherrer D, Schmidlin F, Haddad E, Kassel O, Landry Y, Gies J . Glucocorticoids increase bradykinin B2 receptor gene transcription in cultured guinea-pig tracheal smooth muscle cells. Naunyn Schmiedebergs Arch Pharmacol. 1999; 359(3):153-9. DOI: 10.1007/pl00005337. View

13.

Cuzzocrea S, Chatterjee P, Mazzon E, Dugo L, Serraino I, Britti D . Pyrrolidine dithiocarbamate attenuates the development of acute and chronic inflammation. Br J Pharmacol. 2002; 135(2):496-510. PMC: 1573136. DOI: 10.1038/sj.bjp.0704463. View

14.

Stadnicki A, Pastucha E, Nowaczyk G, Mazurek U, Plewka D, Machnik G . Immunolocalization and expression of kinin B1R and B2R receptors in human inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol. 2005; 289(2):G361-6. DOI: 10.1152/ajpgi.00369.2004. View

15.

Arai Y, Takanashi H, Kitagawa H, Wirth K, Okayasu I . Effect of icatibant, a bradykinin B2 receptor antagonist, on the development of experimental ulcerative colitis in mice. Dig Dis Sci. 1999; 44(4):845-51. DOI: 10.1023/a:1026694732602. View

16.

Cuthbert A, MacVinish L . Transporting epithelia as targets for kinin effects. Adv Exp Med Biol. 1986; 198 Pt A:203-10. DOI: 10.1007/978-1-4684-5143-6_28. View

17.

Jarnerot G, Hertervig E, Friis-Liby I, Blomquist L, Karlen P, Granno C . Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. Gastroenterology. 2005; 128(7):1805-11. DOI: 10.1053/j.gastro.2005.03.003. View

18.

Phagoo S, Poole S . Autoregulation of bradykinin receptors: agonists in the presence of interleukin-1beta shift the repertoire of receptor subtypes from B2 to B1 in human lung fibroblasts. Mol Pharmacol. 1999; 56(2):325-33. DOI: 10.1124/mol.56.2.325. View

19.

Bradford M . A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976; 72:248-54. DOI: 10.1016/0003-2697(76)90527-3. View

20.

Shi X, Semkova I, Muther P, Dell S, Kociok N, Joussen A . Inhibition of TNF-alpha reduces laser-induced choroidal neovascularization. Exp Eye Res. 2006; 83(6):1325-34. DOI: 10.1016/j.exer.2006.07.007. View